No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CTVA240621C55000
- 0.17
- +0.12+240.00%
15min DelayClose Jun 18 15:59 ET
0.30High0.17Low
0.30Open0.05Pre Close3 Volume7.68K Open Interest55.00Strike Price64.00Turnover66.74%IV6.32%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.17Extrinsic Value100Contract SizeAmericanOptions Type0.1098Delta0.0781Gamma415.12Leverage Ratio-0.1074Theta0.0003Rho45.58Eff Leverage0.0068Vega
Intraday
- 5D
- Daily
News
Mizuho Securities Maintains Corteva(CTVA.US) With Buy Rating, Cuts Target Price to $60
Mizuho Securities analyst Edlain Rodriguez maintains $Corteva(CTVA.US)$ with a buy rating, and adjusts the target price from $61 to $60.According to TipRanks data, the analyst has a success rate of 56
Corteva Is Maintained at Buy by Mizuho
Corteva Is Maintained at Buy by Mizuho
Express News | Corteva Inc : Mizuho Cuts Target Price to $60 From $61
Mizuho Securities Adjusts Price Target on Corteva to $60 From $61
Corteva (CTVA) has an average rating of outperform and price targets ranging from $54 to $70, according to analysts polled by Capital IQ. Price: 52.57, Change: +0.53, Percent Change: +1.02
BofA Securities Maintains Corteva(CTVA.US) With Hold Rating
BofA Securities analyst Steve Byrne maintains $Corteva(CTVA.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 0.0% and a total average return of 0.0% over the past
Global Crop Protection Chemicals Market Report 2024, With Profiles of Key Players Adama, BASF, Bayer, CHR. Hansen, Corteva, FMC, Nufarm, Sumitomo Chemical, Syngenta and UPL - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Crop Protection Chemicals Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.The global market for crop protection chemicals is expected
Comments
Morning Movers
Gapping up
$Citigroup(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
Gapping up
$Citigroup(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
27
1
Corteva's rising ROCE and efficient capital use are promising, but growing current liabilities may pose new risks. Despite this, the stock has given a decent 23% return over the past three years, indicating these developments are gaining deserved attention.
1
Corteva's high P/E ratio is sustained by its projected growth surpassing the broader market. Shareholders are at ease with the P/E, confident in the company's future earnings. The share price isn't anticipated to drop significantly soon under these conditions.
The CEO of Lavie Bio, Amit Noam, expressed satisfaction at achieving this milestone with Corteva, stating that the agreement showcases Lavie Bio's technological capabilities and enables the swift introduction of groundbreaking ag-biological solutions.
Corteva's guidance dispels concerns of lower earnings due to falling crop prices. Aptiv's 2024 forecast predicts a 7% sales growth despite stagnant global auto production. TD Cowen analyst Gautam Khanna deems Trane's results as 'good enough', rating the stock as Buy with a $235 price target.
Read more
Peanny : Based on Lies…. The truth is on its way.